Back
Protagonist Therapeutics Vs. EnerSys Industry Stock Comparison
Buy
51
PTGX
Protagonist Therapeutics
Last Price:
31.73
Seasonality Move:
-0.18%
Sell
46
ENS
EnerSys
Last Price:
101.92
Seasonality Move:
-3.09%
Buy
51
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $32.01. The Score for PTGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
EnerSys (ENS)
is a Sell
Is EnerSys a Buy, Sell or Hold?
- The current EnerSys [ENS] share price is $104.11. The Score for ENS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ENS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $32.01
The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
ENS Stock Price Chart
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 52.71 | Buy |
| Chaikin Money Flow: | -255191 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.63 - 33.71) | Buy |
| Bollinger Bands (100): | (26.35 - 31.35) | Buy |
ENS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.53 | Buy |
| Relative Strength Index (14 RSI): | 51.36 | Buy |
| Chaikin Money Flow: | -200032 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.09 - 108.67) | Sell |
| Bollinger Bands (100): | (89.4 - 101.66) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.81 | Sell |
| 20-day SMA: | 31.79 | Buy |
| 50-day SMA: | 29.25 | Buy |
| 200-day SMA: | 23.9 | Buy |
| 8-day EMA: | 32.43 | Sell |
| 20-day EMA: | 31.91 | Buy |
| 50-day EMA: | 30.28 | Buy |
| 200-day EMA: | 25.75 | Buy |
ENS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.44 | Sell |
| 20-day SMA: | 106.32 | Sell |
| 50-day SMA: | 98.94 | Buy |
| 200-day SMA: | 94.67 | Buy |
| 8-day EMA: | 105.29 | Sell |
| 20-day EMA: | 104.55 | Sell |
| 50-day EMA: | 100.84 | Buy |
| 200-day EMA: | 95.56 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
EnerSys Earnings Growth & ENS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.19 per share, an increase this year of $3.41 per share, and an increase next year of $0.37 per share.
Protagonist Therapeutics Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EnerSys Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||